Table of Contents 1 Malaria Vaccines Market Overview 1.1 Product Overview and Scope of Malaria Vaccines 1.2 Malaria Vaccines Segment by Type 1.2.1 Global Malaria Vaccines Sales Growth Rate Comparison by Type (2021-2026) 1.2.2 Pre-Erythrocytic Vaccine 1.2.3 Erythrocytic Vaccine 1.2.4 Multi-antigen Vaccine 1.3 Malaria Vaccines Segment by Application 1.3.1 Malaria Vaccines Sales Comparison by Application: 2020 VS 2026 1.3.2 Hospitals 1.3.3 Clinics 1.3.4 Community Centers 1.4 Global Malaria Vaccines Market Size Estimates and Forecasts 1.4.1 Global Malaria Vaccines Revenue 2015-2026 1.4.2 Global Malaria Vaccines Sales 2015-2026 1.4.3 Malaria Vaccines Market Size by Region: 2020 Versus 2026 2 Global Malaria Vaccines Market Competition by Manufacturers 2.1 Global Malaria Vaccines Sales Market Share by Manufacturers (2015-2020) 2.2 Global Malaria Vaccines Revenue Share by Manufacturers (2015-2020) 2.3 Global Malaria Vaccines Average Price by Manufacturers (2015-2020) 2.4 Manufacturers Malaria Vaccines Manufacturing Sites, Area Served, Product Type 2.5 Malaria Vaccines Market Competitive Situation and Trends 2.5.1 Malaria Vaccines Market Concentration Rate 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 2.7 Primary Interviews with Key Malaria Vaccines Players (Opinion Leaders) 3 Malaria Vaccines Retrospective Market Scenario by Region 3.1 Global Malaria Vaccines Retrospective Market Scenario in Sales by Region: 2015-2020 3.2 Global Malaria Vaccines Retrospective Market Scenario in Revenue by Region: 2015-2020 3.3 North America Malaria Vaccines Market Facts & Figures by Country 3.3.1 North America Malaria Vaccines Sales by Country 3.3.2 North America Malaria Vaccines Sales by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Malaria Vaccines Market Facts & Figures by Country 3.4.1 Europe Malaria Vaccines Sales by Country 3.4.2 Europe Malaria Vaccines Sales by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Malaria Vaccines Market Facts & Figures by Region 3.5.1 Asia Pacific Malaria Vaccines Sales by Region 3.5.2 Asia Pacific Malaria Vaccines Sales by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Malaria Vaccines Market Facts & Figures by Country 3.6.1 Latin America Malaria Vaccines Sales by Country 3.6.2 Latin America Malaria Vaccines Sales by Country 3.6.3 Mexico 3.6.3 Brazil 3.6.3 Argentina 3.7 Middle East and Africa Malaria Vaccines Market Facts & Figures by Country 3.7.1 Middle East and Africa Malaria Vaccines Sales by Country 3.7.2 Middle East and Africa Malaria Vaccines Sales by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Malaria Vaccines Historic Market Analysis by Type 4.1 Global Malaria Vaccines Sales Market Share by Type (2015-2020) 4.2 Global Malaria Vaccines Revenue Market Share by Type (2015-2020) 4.3 Global Malaria Vaccines Price Market Share by Type (2015-2020) 4.4 Global Malaria Vaccines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Global Malaria Vaccines Historic Market Analysis by Application 5.1 Global Malaria Vaccines Sales Market Share by Application (2015-2020) 5.2 Global Malaria Vaccines Revenue Market Share by Application (2015-2020) 5.3 Global Malaria Vaccines Price by Application (2015-2020) 6 Company Profiles and Key Figures in Malaria Vaccines Business 6.1 GlaxoSmithKline plc 6.1.1 Corporation Information 6.1.2 GlaxoSmithKline plc Description, Business Overview and Total Revenue 6.1.3 GlaxoSmithKline plc Malaria Vaccines Sales, Revenue and Gross Margin (2015-2020) 6.1.4 GlaxoSmithKline plc Products Offered 6.1.5 GlaxoSmithKline plc Recent Development 6.2 Sanaria Inc 6.2.1 Sanaria Inc Malaria Vaccines Production Sites and Area Served 6.2.2 Sanaria Inc Description, Business Overview and Total Revenue 6.2.3 Sanaria Inc Malaria Vaccines Sales, Revenue and Gross Margin (2015-2020) 6.2.4 Sanaria Inc Products Offered 6.2.5 Sanaria Inc Recent Development 6.3 Nobelpharma Co 6.3.1 Nobelpharma Co Malaria Vaccines Production Sites and Area Served 6.3.2 Nobelpharma Co Description, Business Overview and Total Revenue 6.3.3 Nobelpharma Co Malaria Vaccines Sales, Revenue and Gross Margin (2015-2020) 6.3.4 Nobelpharma Co Products Offered 6.3.5 Nobelpharma Co Recent Development 6.4 Sumaya Biotech 6.4.1 Sumaya Biotech Malaria Vaccines Production Sites and Area Served 6.4.2 Sumaya Biotech Description, Business Overview and Total Revenue 6.4.3 Sumaya Biotech Malaria Vaccines Sales, Revenue and Gross Margin (2015-2020) 6.4.4 Sumaya Biotech Products Offered 6.4.5 Sumaya Biotech Recent Development 6.5 GenVec 6.5.1 GenVec Malaria Vaccines Production Sites and Area Served 6.5.2 GenVec Description, Business Overview and Total Revenue 6.5.3 GenVec Malaria Vaccines Sales, Revenue and Gross Margin (2015-2020) 6.5.4 GenVec Products Offered 6.5.5 GenVec Recent Development 7 Malaria Vaccines Manufacturing Cost Analysis 7.1 Malaria Vaccines Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Raw Materials Price Trend 7.1.3 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Malaria Vaccines 7.4 Malaria Vaccines Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Malaria Vaccines Distributors List 8.3 Malaria Vaccines Customers 9 Market Dynamics 9.1 Market Trends 9.2 Opportunities and Drivers 9.3 Challenges 9.4 Porter's Five Forces Analysis 10 Global Market Forecast 10.1 Global Malaria Vaccines Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Malaria Vaccines by Type (2021-2026) 10.1.2 Global Forecasted Revenue of Malaria Vaccines by Type (2021-2026) 10.2 Malaria Vaccines Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Malaria Vaccines by Application (2021-2026) 10.2.2 Global Forecasted Revenue of Malaria Vaccines by Application (2021-2026) 10.3 Malaria Vaccines Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Malaria Vaccines by Region (2021-2026) 10.3.2 Global Forecasted Revenue of Malaria Vaccines by Region (2021-2026) 10.4 North America Malaria Vaccines Estimates and Projections (2021-2026) 10.5 Europe Malaria Vaccines Estimates and Projections (2021-2026) 10.6 Asia Pacific Malaria Vaccines Estimates and Projections (2021-2026) 10.7 Latin America Malaria Vaccines Estimates and Projections (2021-2026) 10.8 Middle East and Africa Malaria Vaccines Estimates and Projections (2021-2026) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Malaria Vaccines Sales (K Units) Growth Rate Comparison by Type (2015-2026) Table 2. Global Malaria Vaccines Sales (K Units) Comparison by Application: 2020 VS 2026 Table 3. Global Malaria Vaccines Market Size by Type (K Units) (US$ Million) (2020 VS 2026) Table 4. Global Key Malaria Vaccines Manufacturers Covered in This Study Table 5. Global Malaria Vaccines Sales (K Units) by Manufacturers (2015-2020) Table 6. Global Malaria Vaccines Sales Share by Manufacturers (2015-2020) Table 7. Global Malaria Vaccines Revenue (Million USD) by Manufacturers (2015-2020) Table 8. Global Malaria Vaccines Revenue Share by Manufacturers (2015-2020) Table 9. Global Market Malaria Vaccines Average Price (USD/Unit) of Key Manufacturers (2015-2020) Table 10. Manufacturers Malaria Vaccines Sales Sites and Area Served Table 11. Manufacturers Malaria Vaccines Product Types Table 12. Global Malaria Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Malaria Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Malaria Vaccines as of 2019) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Main Points Interviewed from Key Malaria Vaccines Players Table 16. Global Malaria Vaccines Sales (K Units) by Region (2015-2020) Table 17. Global Malaria Vaccines Sales Market Share by Region (2015-2020) Table 18. Global Malaria Vaccines Revenue (Million US$) by Region (2015-2020) Table 19. Global Malaria Vaccines Revenue Market Share by Region (2015-2020) Table 20. North America Malaria Vaccines Sales by Country (2015-2020) (K Units) Table 21. North America Malaria Vaccines Sales Market Share by Country (2015-2020) Table 22. North America Malaria Vaccines Revenue by Country (2015-2020) (US$ Million) Table 23. North America Malaria Vaccines Revenue Market Share by Country (2015-2020) Table 24. Europe Malaria Vaccines Sales by Country (2015-2020) (K Units) Table 25. Europe Malaria Vaccines Sales Market Share by Country (2015-2020) Table 26. Europe Malaria Vaccines Revenue by Country (2015-2020) (US$ Million) Table 27. Europe Malaria Vaccines Revenue Market Share by Country (2015-2020) Table 28. Asia Pacific Malaria Vaccines Sales by Region (2015-2020) (K Units) Table 29. Asia Pacific Malaria Vaccines Sales Market Share by Region (2015-2020) Table 30. Asia Pacific Malaria Vaccines Revenue by Region (2015-2020) (US$ Million) Table 31. Asia Pacific Malaria Vaccines Revenue Market Share by Region (2015-2020) Table 32. Latin America Malaria Vaccines Sales by Country (2015-2020) (K Units) Table 33. Latin America Malaria Vaccines Sales Market Share by Country (2015-2020) Table 34. Latin America Malaria Vaccines Revenue by Country (2015-2020) (US$ Million) Table 35. Latin America Malaria Vaccines Revenue Market Share by Country (2015-2020) Table 36. Middle East and Africa Malaria Vaccines Sales by Country (2015-2020) (K Units) Table 37. Middle East and Africa Malaria Vaccines Sales Market Share by Country (2015-2020) Table 38. Middle East and Africa Malaria Vaccines Revenue by Country (2015-2020) (US$ Million) Table 39. Middle East and Africa Malaria Vaccines Revenue Market Share by Country (2015-2020) Table 40. Global Malaria Vaccines Sales (K Units) by Type (2015-2020) Table 41. Global Malaria Vaccines Sales Share by Type (2015-2020) Table 42. Global Malaria Vaccines Revenue (Million US$) by Type (2015-2020) Table 43. Global Malaria Vaccines Revenue Share by Type (2015-2020) Table 44. Global Malaria Vaccines Price (USD/Unit) by Type (2015-2020) Table 45. Global Malaria Vaccines Sales (K Units) by Application (2015-2020) Table 46. Global Malaria Vaccines Sales Market Share by Application (2015-2020) Table 47. Global Malaria Vaccines Sales Growth Rate by Application (2015-2020) Table 48. GlaxoSmithKline plc Malaria Vaccines Corporation Information Table 49. GlaxoSmithKline plc Description and Business Overview Table 50. GlaxoSmithKline plc Malaria Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 51. GlaxoSmithKline plc Main Product Table 52. GlaxoSmithKline plc Recent Development Table 53. Sanaria Inc Malaria Vaccines Corporation Information Table 54. Sanaria Inc Corporation Information Table 55. Sanaria Inc Malaria Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 56. Sanaria Inc Main Product Table 57. Sanaria Inc Recent Development Table 58. Nobelpharma Co Malaria Vaccines Corporation Information Table 59. Nobelpharma Co Corporation Information Table 60. Nobelpharma Co Malaria Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 61. Nobelpharma Co Main Product Table 62. Nobelpharma Co Recent Development Table 63. Sumaya Biotech Malaria Vaccines Corporation Information Table 64. Sumaya Biotech Corporation Information Table 65. Sumaya Biotech Malaria Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 66. Sumaya Biotech Main Product Table 67. Sumaya Biotech Recent Development Table 68. GenVec Malaria Vaccines Corporation Information Table 69. GenVec Corporation Information Table 70. GenVec Malaria Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 71. GenVec Main Product Table 72. GenVec Recent Development Table 73. Sales Base and Market Concentration Rate of Raw Material Table 74. Key Suppliers of Raw Materials Table 75. Malaria Vaccines Distributors List Table 76. Malaria Vaccines Customers List Table 77. Market Key Trends Table 78. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 79. Key Challenges Table 80. Global Malaria Vaccines Sales (K Units) Forecast by Type (2021-2026) Table 81. Global Malaria Vaccines Sales Market Share Forecast by Type (2021-2026) Table 82. Global Malaria Vaccines Revenue (Million US$) Forecast by Type (2021-2026) Table 83. Global Malaria Vaccines Revenue (Million US$) Market Share Forecast by Type (2021-2026) Table 84. Global Malaria Vaccines Sales (K Units) Forecast by Application (2021-2026) Table 85. Global Malaria Vaccines Revenue (Million US$) Forecast by Application (2021-2026) Table 86. Global Malaria Vaccines Sales (K Units) Forecast by Region (2021-2026) Table 87. Global Malaria Vaccines Sales Market Share Forecast by Region (2021-2026) Table 88. Global Malaria Vaccines Revenue Forecast by Region (2021-2026) (US$ Million) Table 89. Global Malaria Vaccines Revenue Market Share Forecast by Region (2021-2026) Table 90. Research Programs/Design for This Report Table 91. Key Data Information from Secondary Sources Table 92. Key Data Information from Primary Sources List of Figures Figure 1. Picture of Malaria Vaccines Figure 2. Global Malaria Vaccines Sales Market Share by Type: 2020 VS 2026 Figure 3. Pre-Erythrocytic Vaccine Product Picture Figure 4. Erythrocytic Vaccine Product Picture Figure 5. Multi-antigen Vaccine Product Picture Figure 6. Global Malaria Vaccines Consumption Market Share by Application: 2020 VS 2026 Figure 7. Hospitals Figure 8. Clinics Figure 9. Community Centers Figure 10. Global Malaria Vaccines Market Size 2015-2026 (US$ Million) Figure 11. Global Malaria Vaccines Sales Capacity (K Units) (2015-2026) Figure 12. Global Malaria Vaccines Market Size Market Share by Region: 2020 Versus 2026 Figure 13. Malaria Vaccines Sales Share by Manufacturers in 2020 Figure 14. Global Malaria Vaccines Revenue Share by Manufacturers in 2019 Figure 15. The Global 5 and 10 Largest Players: Market Share by Malaria Vaccines Revenue in 2019 Figure 16. Malaria Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 17. Global Malaria Vaccines Sales Market Share by Region (2015-2020) Figure 18. Global Malaria Vaccines Sales Market Share by Region in 2019 Figure 19. Global Malaria Vaccines Revenue Market Share by Region (2015-2020) Figure 20. Global Malaria Vaccines Revenue Market Share by Region in 2019 Figure 21. North America Malaria Vaccines Sales Market Share by Country in 2019 Figure 22. North America Malaria Vaccines Revenue Market Share by Country in 2019 Figure 23. U.S. Malaria Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 24. U.S. Malaria Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 25. Canada Malaria Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 26. Canada Malaria Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 27. Europe Malaria Vaccines Sales Market Share by Country in 2019 Figure 28. Europe Malaria Vaccines Revenue Market Share by Country in 2019 Figure 29. Germany Malaria Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 30. Germany Malaria Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 31. France Malaria Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 32. France Malaria Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 33. U.K. Malaria Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 34. U.K. Malaria Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 35. Italy Malaria Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 36. Italy Malaria Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 37. Russia Malaria Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 38. Russia Malaria Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 39. Asia Pacific Malaria Vaccines Sales Market Share by Region in 2019 Figure 40. Asia Pacific Malaria Vaccines Revenue Market Share by Region in 2019 Figure 41. China Malaria Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 42. China Malaria Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 43. Japan Malaria Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 44. Japan Malaria Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 45. South Korea Malaria Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 46. South Korea Malaria Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 47. India Malaria Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 48. India Malaria Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 49. Australia Malaria Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 50. Australia Malaria Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 51. Taiwan Malaria Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 52. Taiwan Malaria Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 53. Indonesia Malaria Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 54. Indonesia Malaria Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 55. Thailand Malaria Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 56. Thailand Malaria Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 57. Malaysia Malaria Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 58. Malaysia Malaria Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 59. Philippines Malaria Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 60. Philippines Malaria Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 61. Vietnam Malaria Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 62. Vietnam Malaria Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 63. Latin America Malaria Vaccines Sales Market Share by Country in 2019 Figure 64. Latin America Malaria Vaccines Revenue Market Share by Country in 2019 Figure 65. Mexico Malaria Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 66. Mexico Malaria Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 67. Brazil Malaria Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 68. Brazil Malaria Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 69. Argentina Malaria Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 70. Argentina Malaria Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 71. Middle East and Africa Malaria Vaccines Sales Market Share by Country in 2019 Figure 72. Middle East and Africa Malaria Vaccines Revenue Market Share by Country in 2019 Figure 73. Turkey Malaria Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 74. Turkey Malaria Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 75. Saudi Arabia Malaria Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 76. Saudi Arabia Malaria Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 77. U.A.E Malaria Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 78. U.A.E Malaria Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 79. Sales Market Share of Malaria Vaccines by Type (2015-2020) Figure 80. Sales Market Share of Malaria Vaccines by Type in 2019 Figure 81. Revenue Share of Malaria Vaccines by Type (2015-2020) Figure 82. Revenue Market Share of Malaria Vaccines by Type in 2019 Figure 83. Global Malaria Vaccines Sales Growth by Type (2015-2020) (K Units) Figure 84. Global Malaria Vaccines Sales Market Share by Application (2015-2020) Figure 85. Global Malaria Vaccines Sales Market Share by Application in 2019 Figure 86. Global Revenue Share of Malaria Vaccines by Application (2015-2020) Figure 87. Global Revenue Share of Malaria Vaccines by Application in 2020 Figure 88. GlaxoSmithKline plc Total Revenue (US$ Million): 2019 Compared with 2018 Figure 89. Sanaria Inc Total Revenue (US$ Million): 2019 Compared with 2018 Figure 90. Nobelpharma Co Total Revenue (US$ Million): 2019 Compared with 2018 Figure 91. Sumaya Biotech Total Revenue (US$ Million): 2019 Compared with 2018 Figure 92. GenVec Total Revenue (US$ Million): 2019 Compared with 2018 Figure 93. Price Trend of Key Raw Materials Figure 94. Manufacturing Cost Structure of Malaria Vaccines Figure 95. Manufacturing Process Analysis of Malaria Vaccines Figure 96. Malaria Vaccines Industrial Chain Analysis Figure 97. Channels of Distribution Figure 98. Distributors Profiles Figure 99. Porter's Five Forces Analysis Figure 100. North America Malaria Vaccines Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 101. North America Malaria Vaccines Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 102. Europe Malaria Vaccines Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 103. Europe Malaria Vaccines Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 104. Latin America Malaria Vaccines Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 105. Latin America Malaria Vaccines Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 106. Middle East and Africa Malaria Vaccines Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 107. Middle East and Africa Malaria Vaccines Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 108. Asia Pacific Malaria Vaccines Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 109. Asia Pacific Malaria Vaccines Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 110. Bottom-up and Top-down Approaches for This Report Figure 111. Data Triangulation Figure 112. Key Executives Interviewed

GlaxoSmithKline plc Sanaria Inc Nobelpharma Co Sumaya Biotech GenVec